Apogee Therapeutics, Inc.

Q1 2024 13F Holders

Symbol
APGE
CUSIP
03770N101
Type
Equity
Class
COM
Num filings
147
Total reported value, excl. options
$3.54 B
Manager Report Date Value ($000) Shares Option Type